SPINK1 and ovarian cancer: Notably, SPINK1 shows promise as an early diagnostic biomarker: its concentration increases by 1000-fold in malignant ovarian tumors (23, 24), and it exhibits diagnostic relevance in both hepatocellular and pancreatic malignancies (25, 26).